Literature DB >> 13513904

Localization of streptococcal antigens in tissues. I. Histologic distribution and persistence of M protein, types 1, 5, 12, and 19 in the tissues of the mouse.

M H KAPLAN.   

Abstract

A method has been described for the detection of streptococcal antigens in tissues using the indirect immunofluorescent technique. This method has been applied to the histologic distribution in the mouse of M protein of types 1, 5, 12, and 19. Histologic localization of these M proteins was similar, and their rates of disappearance from the tissues were comparable. The major sites of deposition were the endocardium and adjacent subendocardium of the heart, alveolar walls of the lung, glomerular tufts of the kidney, and reticulo-endothelial cells of liver, spleen, lymph nodes, and adrenal gland. M protein was distributed in considerably lesser concentration in capillary endothelium and connective tissue sites in myocardium, kidney, skin, and gastrointestinal tract. Traces were also present in adrenal cortical cells. It was observed only rarely in cell nuclei. After injection of 0.5 mg. M protein fraction, the concentration of antigen diminished to undetectable levels in all organ sites by 4 days, except in the renal glomerulus, where traces were visible at 8 days. In mice injected with streptococcal culture intraperitoneally, M protein was detected at sites of focal abscesses in liver and spleen, and on the serous surfaces of these organs. The histologic distribution of M protein is compared with that described previously for pneumococcal polysaccharide and animal protein. Differences in the extent of distribution and in the characteristics of antigen deposition are pointed out.

Entities:  

Keywords:  STREPTOCOCCAL INFECTIONS/immunology

Mesh:

Substances:

Year:  1958        PMID: 13513904      PMCID: PMC2136689          DOI: 10.1084/jem.107.3.341

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  The quantitative precipitin reaction of type 19 M protein antigen of group A streptococci and antistreptococcal rabbit sera.

Authors:  W C SCHMIDT
Journal:  J Immunol       Date:  1957-03       Impact factor: 5.422

2.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

3.  Acute glomerulonephritis, the significance of the variations in the incidence of the disease.

Authors:  C H RAMMELKAMP; R S WEAVER
Journal:  J Clin Invest       Date:  1953-04       Impact factor: 14.808

4.  The cellular transfer in humans of delayed cutaneous reactivity to hemolytic streptococci.

Authors:  H S LAWRENCE
Journal:  J Immunol       Date:  1952-02       Impact factor: 5.422

5.  THE ISOLATION OF THE BLOOD GROUP A SPECIFIC SUBSTANCE FROM COMMERCIAL PEPTONE.

Authors:  W F Goebel
Journal:  J Exp Med       Date:  1938-07-31       Impact factor: 14.307

6.  THE SIGNIFICANCE OF M AND T ANTIGENS IN THE CROSS REACTIONS BETWEEN CERTAIN TYPES OF GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1940-03-31       Impact factor: 14.307

7.  Localization of antigen in tissue cells. VI. The fate of injected foreign proteins in the mouse.

Authors:  A H COONS; E H LEDUC; M H KAPLAN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

8.  VARIANTS OF HEMOLYTIC STREPTOCOCCI; THEIR RELATION TO TYPE-SPECIFIC SUBSTANCE, VIRULENCE, AND TOXIN.

Authors:  E W Todd; R C Lancefield
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

9.  Localization of antigen in tissue cells; V. Capsular polysaccharide of Friedländer bacillus, type B, in the mouse.

Authors:  A G S HILL; H W DEANE; A H COONS
Journal:  J Exp Med       Date:  1950-07-01       Impact factor: 14.307

10.  BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS.

Authors:  S Rothbard
Journal:  J Exp Med       Date:  1945-08-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis.

Authors:  T Matthew Eison; Bettina H Ault; Deborah P Jones; Russell W Chesney; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2010-07-23       Impact factor: 3.714

2.  IMMUNOFLUORESCENT STAINING: THE FLUORESCENT ANTIBODY METHOD.

Authors:  E H Beutner
Journal:  Bacteriol Rev       Date:  1961-03

3.  Routine immunofluorescent microscopy in renal diseases.

Authors:  A H Nagi
Journal:  Ir J Med Sci       Date:  1973-05       Impact factor: 1.568

4.  Experimental Escherichia coli pyelonephritis: formation of spheroplasts in the kidney of the untreated rat.

Authors:  J Demonty
Journal:  Antonie Van Leeuwenhoek       Date:  1970       Impact factor: 2.271

Review 5.  Streptococcal rheumatic carditis.

Authors:  S K Unny; B L Middlebrooks
Journal:  Microbiol Rev       Date:  1983-03

6.  TYPING OF GROUP A STREPTOCOCCI BY IMMUNOFLUORESCENCE. I. PREPARATION AND PROPERTIES OF TYPE I FLUORESCEIN-LABELED ANTIBODY.

Authors:  W W KARAKAWA; E K BORMAN; C R MCFARLAND
Journal:  J Bacteriol       Date:  1964-06       Impact factor: 3.490

7.  DETECTION AND PERSISTENCE OF VI ANTIGEN IN TISSUES OF ACTIVELY IMMUNIZED MICE.

Authors:  S GAINES; J A CURRIE; J G TULLY
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

8.  Renal glomerular lesions in mice following injection of strreptococcal M protein.

Authors:  F S KANTOR
Journal:  Yale J Biol Med       Date:  1961-08

9.  Studies on fluorescent antibody staining. I. Non-specific fluorescence with fluorescein-coupled sheep anti-rabbit globulins.

Authors:  G GOLDSTEIN; I S SLIZYS; M W CHASE
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

10.  FIBROGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. II. RENAL LESIONS INDUCED BY INTRAVENOUS INJECTION OF M PROTEIN INTO MICE AND RATS.

Authors:  F S KANTOR
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.